4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-22-049368
President and CEO sold 20,000 shares at $12.89 ($257,800)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jiang Wenbin President and CEO | 2022-09-07 | Sale | −20,000 | $12.89 | $257,800 | 7,825,820 | D |
| Open-market sales · 20,000 sh · avg $12.89 · $257,800 | |||||||
Loading xslF345X03/doc4.xml…